Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets lei 2017.62 lei 67.31 lei 6058.04
  • Free AirMail shipping
60 tablets lei 1075.90 lei 71.80 lei 4307.87
  • Free AirMail shipping
30 tablets lei 403.44 lei 76.28 lei 2288.45
  • Free AirMail shipping
20 tablets lei 179.28 lei 80.77 lei 1615.31
  • Free AirMail shipping
10 tablets lei 89.73 lei 897.30
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets lei 805.97 lei 80.77 lei 7269.69
  • Free AirMail shipping
60 tablets lei 402.76 lei 83.02 lei 4981.01
  • Free AirMail shipping
30 tablets lei 134.18 lei 85.26 lei 2557.71
  • Free AirMail shipping
20 tablets lei 44.65 lei 87.50 lei 1749.94
  • Free AirMail shipping
10 tablets lei 89.73 lei 897.30
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets lei 1007.91 lei 96.48 lei 8683.28
  • Free AirMail shipping
60 tablets lei 537.39 lei 98.72 lei 5923.41
  • Free AirMail shipping
30 tablets lei 201.49 lei 100.96 lei 3028.91
  • Free AirMail shipping
20 tablets lei 89.53 lei 103.20 lei 2064.07
  • Free AirMail shipping
10 tablets lei 107.68 lei 1076.80
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.